If OI occurs when the norepinephrine transporter is inhibited, then impairments with the norepinephrine transporter could help explain the cognitive impairments and mental cloudiness associated among patients with CFS and POTS. The gene discussed is SLC6A2; the disease is osteogenesis imperfecta.